QOL benefits observed as early as week 2 with peginterferon alfa-2a (40KD) (PEGASYS) in combination with ribavirin (RBV) versus interferon alfa-2b plus RBV
Year: 2002
Type: article
Source: Journal of Hepatology
Authors: T.I. Hassanien, W.G.E. Cooksley, M. Sulkowski, C. Smith, G. Marinos, M.-Y. Lai, G. Pastore, R. Trejo-Estrada, A. Horta, E. Vale, N.S. Winfield, M. Neary, J. Green
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1975840406